AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24251579
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of an oral glucose-lowering agent
Trial: 24251579
Drug: Commencement of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commencement of insulin
Trial: 17931940
Drug: Cr, Er:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cr, Er: YSGG laser treatment for 40 seconds
Trial: 12044126
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine (2 mg/kg of body weight)
Trial: 12044126
Drug: Placebo (lidocaine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lidocaine, 2 mg/kg)
Trial: 10448262
Drug: Onapristone 100
RxNorm normalized name: Onapristone
DrugBank: Onapristone (DB12637)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onapristone 100 mg/day
Trial: 7884433
Drug: Carboplatin and
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin and cyclophosphamide combination therapy
Trial: 17577460
Drug: Doxazosin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin monotherapy
Trial: 17577460
Drug: Finasteride monotherapy
RxNorm normalized name: Finasteride
DrugBank: Finasteride (DB01216)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Finasteride monotherapy
Trial: 2551088
Drug: Prophylactic low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prophylactic low-dose heparin/dihydroergotamine
Trial: 2551088
Drug: Low-molecular heparin/dihydroergotamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular heparin/dihydroergotamine
Trial: 7318622
Drug: Conventional mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mechanical bowel preparation
Trial: 19693492
Drug: Varenicline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (1 mg/day)
Trial: 15231554
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (psychotherapy + antidepressants)
Trial: 11277173
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human thrombopoietin (rhTPO) administered intravenously by bolus injection at doses ranging from 0.3 to 4.8 microg/kg/day every 3 days and 0.6 microg/kg daily to three patients.
Trial: 11277173
Drug: G-CSF administered
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administered concomitantly to promote myeloid recovery.
Trial: 9863499
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of four virostatics affecting four targets
Trial: 9863499
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of three virostatics affecting three targets
Trial: 9863499
Drug: Shorter (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter (3 week) sequences of drug combinations
Trial: 8307046
Drug: Ceftriaxone 2
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 2 g once daily for two days
Trial: 8307046
Drug: Penicillin G
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin G standard regimen for six days
Trial: 30171341
Drug: Soft laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft laser therapy (15 sessions over 3 weeks)
Trial: 30171341
Drug: Shockwave therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shockwave therapy (3 treatments over 3 weeks)
Trial: 22133037
Drug: Sensor-Augmented Pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor-Augmented Pump Therapy (SAPT)
Trial: 22133037
Drug: Multiple Daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple Daily Injection (MDI) therapy with self-monitoring of blood glucose (SMBG)
Trial: 12385596
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg S-PS daily
Trial: 12385596
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg S-PS daily
Trial: 7481155
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment (various types)
Trial: 7481155
Drug: Streptokinase +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase + Aspirin
Trial: 7481155
Drug: Streptokinase +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase + Aspirin + Heparin
Trial: 7481155
Drug: Aspirin-accelerated t-PA-heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin-accelerated t-PA-heparin
Trial: 2393076
Drug: Atracurium 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.125 mg/kg after initial dose of Atracurium 0.5 mg/kg
Trial: 2393076
Drug: Atracurium 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.125 mg/kg after Alcuronium 0.25 mg/kg
Trial: 6778240
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate oral
Trial: 28836470
Drug: EMLA 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMLA 5% cream applied daily for 4 weeks as a primary dressing
Trial: 23340894
Drug: IDeg OD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDeg OD Flex (once-daily insulin degludec with 8-40 hour intervals)
Trial: 23340894
Drug: IDeg OD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDeg OD (once-daily insulin degludec at the main evening meal)
Trial: 23340894
Drug: IGlar OD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGlar OD (once-daily insulin glargine at the same time each day)
Trial: 21087125
Drug: Pocket-sized containers
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pocket-sized containers of alcohol-based gel, reminder materials, and education for all healthcare workers (HCWs)
Trial: 15558381
Drug: Constraint-Induced Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-Induced Therapy (CIT)
Trial: 15335180
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of manidipine
Trial: 15335180
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of cilnidipine
Trial: 11218763
Drug: Intrathecal nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal nicardipine administration (12 ml daily dose, 8 mg of nicardipine for 14 days)
Trial: 11218763
Drug: Intrathecal nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal nicardipine administration
Trial: 9052891
Drug: Amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (10 mg UID)
Trial: 9052891
Drug: Nifedipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (60 mg UID)
Trial: 9052891
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 mg BID)
Trial: 9052891
Drug: Doxazosin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (4 mg UID)
Trial: 27754805
Drug: Testosterone (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (7.5 g of 1% testosterone gel daily for 3 years)
Trial: 27754805
Drug: Placebo (gel)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (gel)
Trial: 26328600
Drug: Substitution of
RxNorm normalized name: hydroxypropyl cellulose, low substituted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substitution of 100 g/d sugary drinks with 100 g/d milk
Trial: 22959781
Drug: Cinacalcet (calcium-sensing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet (calcium-sensing receptor agonist)
Trial: 16896836
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg meloxicam for 1 month
Trial: 16896836
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets for 1 month
Trial: 10655195
Drug: Timolol-pilocarpine fixed
RxNorm normalized name: pilocarpine / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol-pilocarpine fixed combination twice daily
Trial: 28337899
Drug: Ketoprofen (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (single dose 30 minutes prior to extraction)
Trial: 28337899
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug administration before extraction)
Trial: 24145423
Drug: Pharmacological intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmacological intervention targeting the neuroactive ligand-receptor interaction gene set
Trial: 21390581
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg/(kg·d) for three days)
Trial: 21390581
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment and Chinese herbal decoction for purgation)
Trial: 19641900
Drug: Anti-psychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-psychotic treatment (duration: 3 weeks)
Trial: 19641900
Drug: Anti-psychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-psychotic treatment (duration: 8 weeks)
Trial: 19641900
Drug: Anti-psychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-psychotic treatment (duration: 3 and 8 weeks)
Trial: 12064377
Drug: Enalapril/Hydrochlorothiazide 20/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril/Hydrochlorothiazide 20/12.5 mg tablets
Trial: 12064377
Drug: Control formulation
RxNorm normalized name: nut.tx, weight loss-control formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control formulation of Enalapril/Hydrochlorothiazide 20/12.5 mg tablets
Trial: 6798049
Drug: Mechanical irrigation
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical irrigation with a 10% mannitol solution
Trial: 6798049
Drug: Conventional preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional preparations by digestive tract irrigation with or without intestinal antibiotics
Trial: 6798049
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of antibiotics (neomycin, metronidazole by mouth)
Trial: 6235682
Drug: Combination preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination preparation of benzoyl peroxide and miconazole cream
Trial: 6235682
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide and oral tetracycline
Trial: 23103906
Drug: Warfarin (Control)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (Control)
Trial: 27638053
Drug: 300 IU
RxNorm normalized name: Follistim AQ 300 IU per 0.36 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 IU of highly purified menotrophin as single subcutaneous and intramuscular doses
Trial: 27638053
Drug: 300 IU
RxNorm normalized name: Follistim AQ 300 IU per 0.36 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 IU of highly purified urofollitrophin as single subcutaneous doses
Trial: 27638053
Drug: 225 IU
RxNorm normalized name: Ascorbic Acid/Calcium Pantothenate/Cyanocobalamin/Iron/Niacin/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin D/Vitamin E/Zinc 200 MG-18.4 MG-0.005 MG-12 MG-100 MG-4.1 MG-10 MG-0.3 MG-10000 IU-400 IU-225 IU-1.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 225 IU of hp‐FSH as single subcutaneous doses
Trial: 27638053
Drug: daily 225
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: daily 225 IU of hp‐FSH as subcutaneous doses for 5 consecutive days
Trial: 25055938
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg/day plus tegafur-uracil 400 mg/day (TU) for 2 years
Trial: 25055938
Drug: Tamoxifen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen plus doxorubicin (40 mg/m2) and cyclophosphamide (500 mg/m2) (ACT) for 2 years
Trial: 25055938
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg/day plus tegafur-uracil 400 mg/day (TU)
Trial: 10563034
Drug: Alcohol administered
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol administered (3 alcoholic drinks each containing approximately 10 g of pure alcohol)
Trial: 10563034
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered (equivalent non-alcoholic beverage)
Trial: 1684155
Drug: RU 41,656
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 41,656 10 mg
Trial: 1684155
Drug: Scopolamine 0.6
RxNorm normalized name: scopolamine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine 0.6 mg s.c.
Trial: 6355542
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and sulfinpyrazone
Trial: 30778028
Drug: Topiramate, up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate, up to 100 mg daily for three months
Trial: 24731891
Drug: Lavender inhalation
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lavender inhalation based on sesame oil
Trial: 18930550
Drug: Intraoperative 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative 5-fluorouracil (5-FU) 50 mg/ml for 5 minutes
Trial: 11151233
Drug: Intraoperative mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative mitomycin C (MMC) 0.2 mg/ml for 2 minutes
Trial: 17215195
Drug: Inulin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin (0.25 g/kg/d for 3 weeks)
Trial: 15827896
Drug: L-carnitine 20
RxNorm normalized name: L-Carnitine 200mg/1mL Solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine 20 mg/kg, thrice weekly for 6 months
Trial: 9587725
Drug: Tramadol 3
RxNorm normalized name: TRAMADOL 300MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 3 mg kg‐1 (n = 20) administered intravenously at the beginning of wound closure
Trial: 9587725
Drug: Tramadol 3
RxNorm normalized name: TRAMADOL 300MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 3 mg kg‐1 (n = 20)
Trial: 8790652
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg on the first day, followed by 100 mg for the next nine days)
Trial: 4985446
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection of diluted smallpox vaccine with a titre of 10(7) TCID(50)/ml
Trial: 4985446
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection of diluted smallpox vaccine with a titre of 10(6) TCID(50)/ml
Trial: 4985446
Drug: Multiple-pressure inoculation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-pressure inoculation of undiluted vaccine
Trial: 17334580
Drug: Dengue antibody
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dengue antibody prevalence
Trial: 15334857
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) 5000 U subcutaneously every 12 hours
Trial: 15334857
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) 5000 U subcutaneously every 8 hours
Trial: 11710505
Drug: Methylprednisolone (plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (plus an antiviral agent?)
Trial: 11710505
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment for viral inflammation
Trial: 9024022
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate salt 12.5 mg
Trial: 9024022
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate salt 25 mg
Trial: 9024022
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate salt 50 mg
Trial: 7908187
Drug: Intravenous beta‐blocking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous beta‐blocking agents
Trial: 7908187
Drug: Glucose‐insulin‐potassium (GIK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose‐insulin‐potassium (GIK) therapy
Trial: 7908187
Drug: Newer anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newer anticoagulant and antithrombotic agents (hirudin and Hirulog)
Trial: 7908187
Drug: Newer thrombolytic
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newer thrombolytic drugs (recombinant plasminogen activator - r‐PA)
Trial: 7908187
Drug: Surfactant and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant and emulsifying agents (Rheothrx)
Trial: 24382836
Drug: Active Low-Level
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Low-Level Laser Therapy (LLLT)
Trial: 24382836
Drug: Placebo Low-Level
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Low-Level Laser Therapy (LLLT)
Trial: 8181024
Drug: Thiazide-type diuretic
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide-type diuretic or low-dose loop diuretic
Trial: 8181024
Drug: Large-dose loop
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-dose loop diuretic combined with thiazide-type diuretic
Trial: 8181024
Drug: Intermittent intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent intravenous loop diuretic; short-term infusion of a loop diuretic; intensified combination oral diuretic therapy; intravenous positive inotropic therapy; ultrafiltration or dialysis
Trial: 2691821
Drug: 312 g
RxNorm normalized name: BENZALKONIUM CHLORIDE 0.312 g in 240 mL TOPICAL SOLUTION [VitaVie]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 312 g of carbohydrate (H)
Trial: 2691821
Drug: 45 g
RxNorm normalized name: SODIUM CHLORIDE 0.045 g in 5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 g of carbohydrate (L)
Trial: 2691821
Drug: 156 g
RxNorm normalized name: MENTHOL, UNSPECIFIED FORM 0.156 g TOPICAL PATCH [BLACK ICE MEDICATED PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 156 g of carbohydrate (M)
Trial: 2691821
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of carbohydrate (P)
Trial: 4557308
Drug: BX24 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BX24 300 mg daily
Trial: 4557308
Drug: BX24 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BX24 600 mg daily
Trial: 4557308
Drug: BX24 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BX24 1200 mg daily
Trial: 4557308
Drug: BX24 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BX24 300 mg daily with zinc sulphate 660 mg daily
Trial: 4557308
Drug: BX24 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BX24 300 mg daily without zinc sulphate
Trial: 4557308
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A 50,000 units daily
Trial: 28766349
Drug: G-CSF administered
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administered at 10:00
Trial: 28766349
Drug: G-CSF administered
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administered at 14:00
Trial: 20732799
Drug: Soy isoflavones
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isoflavones group (200 mg of Glycine max, 80 mg of isoflavone)